Skip Navigation
Mortar_and_pestel

Regimen Information

For Cisplatin + Gemzar, including Side Effects

Cisplatin + Gemzar

Drugs in this Regimen:

For the treatment of Non-Small Cell Lung Cancer

How Cisplatin + Gemzar chemotherapy is given and possible side effects.

Cisplatin + Gemzar for the treatment of Non-Small Cell Lung Cancer

Cisplatin + Gemzar (gemcitabine) is used in the treatment of non-small cell lung cancer.

MOST COMMON SIDE EFFECTS OF CISPLATIN + GEMZAR

  • Risk of Infection

  • Anemia

  • Bleeding

  • Nausea & Vomiting

For more information, see the 'Expert Resources' tab below.

Community Responses

Often, the most helpful information regarding treatment side effects comes not from clinical brochures, but rather from other patients like you. We've collected the most helpful community resources to help you prepare for the side effects and coping tips for your chemotherapy regimen.

What side effects did you experience while on this medication?

Hi, I'm Melle

Ringing in the ears (tinnitus), severe nausea and vomiting resulting in dehydration, weight loss of 7 pounds in four days and that didn’t include the 6 pound fluid weight loss (but don’t recommend this diet), fatigue, infection and spent four days in the hospital. That was just with the first treatment. Other than that, it was a piece of cake….

  • Fri Jan 25, 2013

This discussion needs your voice!

What were the specific side effects that you experienced while taking this medication? How did you manage them?

What coping tips would you give to new patients on this regimen?

There are currently no answers to this question. Be the first to answer!

This discussion needs your voice!

What do you wish you had known before taking this medication? What information would you like to pass on to patients who are beginning this medication?

Treatment Overview

This chemotherapy regimen is commonly used to treat:

See Expert Resources

The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the the National Cancer Institute and other experts.